Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caner Civan

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2026
PSMA-PET response under [<sup>177</sup>Lu]Lu-PSMA therapy: Comparison of RECIST, PERCIST, PPP, adapted PCWG4 and RECIP criteriaTugce Telli, Madeleine J Karpinski, Robert Seifert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective StudyCaner Civan, Stefan Kasper, Christoph Berliner, et al.
European Urology|October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE RegistryMadeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2026
PSMA-PET response under [<sup>177</sup>Lu]Lu-PSMA therapy: Comparison of RECIST, PERCIST, PPP, adapted PCWG4 and RECIP criteriaTugce Telli, Madeleine J Karpinski, Robert Seifert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective StudyCaner Civan, Stefan Kasper, Christoph Berliner, et al.
European Urology|October 30, 2025
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE RegistryMadeleine J Karpinski, Sebastian Hoberück, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
The Lancet. Oncology|March 12, 2026
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort studyMadeleine J Karpinski, Caner Civan, Isabel Rauscher, et al.
Pageof 3